Integrating RetinAI Discovery Clinics in a Real World Setting Addressing AMD & GA

Webinar Length: 40 minutes followed by 30 minutes of Q&As

‍

‍
How can AI-driven solutions reshape diagnostics, patient care, and research in the field of retinal disease, especially for Age-related Macular Degeneration (AMD) and Geographic Atrophy (GA)?

In this presentation, Dr. Aude Ambresin shares her own experience on how AI technology revolutionized AMD management in her Clinic, improving patient outcomes and driving new efficiencies in both clinical practice and research.

‍

Key takeaways:

• Optimizing the Patient Journey
  ‍See how AI can enhance diagnostics, streamline treatment, and offer a more personalized experience for patients
  ‍
• Advancing Imaging Analysis
  Witness the power of automated segmentation of retinal layers and fluid volumes with the RetinAI Discovery® platform
  ‍
• Boosting Clinical Research
  ‍Learn how AI accelerates insights, enabling faster decision-making and more effective studies in AMD and Geographic Atrophy (GA)

Bonus: The presentation features a Q&A session, where Dr. Ambresin and the RetinAI team address common questions and provide practical examples.
‍

‍

‍
You’ll hear from guest Dr. Aude Ambresin, Medical Director and Associate Founder of the RétinElysée Private Retina Center in Lausanne, Switzerland. She is also Medical Retina Referent at Swiss Visio Montchoisi, a private ophthalmology clinic, and a lecturer at the faculty of medicine in Lausanne. She leads a clinical trial unit dedicated to retinal diseases, particularly age-related macular degeneration, and integrates new technologies and AI in her research.

‍

‍

Watch the webinar now:

‍